Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

Market Cap	8.10B -11.9%
Revenue (ttm)	1.81B -10.1%
Net Income	24.02M -92.0%
EPS	0.04 -92.5%
Shares Out	571.39M
PE Ratio	337.09
Forward PE	20.42
Dividend	0.21 (1.48%)
Ex-Dividend Date	Jun 27, 2025

Volume	4,001,374
Average Volume	5,299,020
Open	14.10
Previous Close	14.14
Day's Range	14.01 - 14.25
52-Week Range	13.51 - 17.68
Beta	0.54
RSI	50.37
Earnings Date	Apr 29, 2026

About Shenzhen YHLO Biotech

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers chemiluminescence immunoassay analyzer, diabetes solution, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,678
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688575

Financial Performance

In 2025, Shenzhen YHLO Biotech's revenue was 1.81 billion, a decrease of -10.07% compared to the previous year's 2.01 billion. Earnings were 24.02 million, a decrease of -92.03%.